secwatch.observer — SEC 8-K summary
======================================

Issuer:     Celularity Inc (CELU)
CIK:        0001752828
Form:       8-K
Filed at:   2022-10-06T23:59:59+00:00
Accession:  0001193125-22-258852
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Celularity names John R. Haines as Sr. EVP & CAO; Bradley Glover promoted to EVP & COO
--------------------------------------------------------------------------------

- Haines named Senior EVP, General Manager and Chief Administrative Officer effective Oct 4, 2022; base salary raised to $500K from $450K.
- Glover promoted to EVP and Chief Operating Officer, succeeding Haines as principal operating officer; salary increased to $450K from $400K.
- Glover previously served as EVP and CTO since 2021; background includes roles at Kite Pharma and Genentech.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1752828/000119312522258852/0001193125-22-258852-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1752828/000119312522258852/d380272d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-258852

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer